United Kingdom

Rethinking the Growth Capital Challenge in UK Life Sciences

Matthew Appleton

Investors, entrepreneurs and deal makers in the UK Life Sciences industry met on the 28 September 2018 to share ideas on how to close the funding gap which exists for UK businesses in the period between early stage investment and IPO. At a lively panel discussion sponsored by LSX Connect and hosted by Allen & Read More

UK Department for Health and Social Care publishes an initial code of conduct for use of digital technology

Emma Keeling

As big data continues to be big news and data protection law continues to evolve, it is timely that the Department for Health and Social Care (the Department) has published a code of conduct relating to the use of data-driven health and care technology (the Code). Published in its initial form on Wednesday, the code Read More

UK government publishes plans for the Life Sciences sector in the event of a no-deal Brexit

Jacqueline Bore

The UK government has published a series of guidance documents setting out how it plans to regulate the Life Sciences sector if the UK leaves the European Union on 29 March 2019 without an agreement with the remaining EU-27 Member States. The UK government emphasizes that significant progress has been made in negotiations with the Read More

Brexit White Paper: UK’s proposals on future relationship with EU acknowledge the needs of the Life Sciences industries

Jacqueline Bore

The UK government published its long awaited White Paper, “The Future Relationship between the United Kingdom and Europe”, on 12 July 2018.  The White Paper details the UK government’s comprehensive vision for the future relationship between the UK and the EU-27, which it describes as the “Future Framework”. The proposals that affect the Life Sciences Read More

SPCs and Brexit: SPC applications pending in the UK at the end of the “transition period” will still be granted

Steven Baldwin

EU and UK Brexit negotiators have agreed that applications for Supplementary Protection Certificates (SPCs) for plant products and medicinal products submitted in the UK before the end of the Brexit “transition period” (currently 31 December 2020) will: Still be granted after the end of that period; and Provide for the same level of protection as Read More